“…Ibopamine [69], a prodrug form of Nmethyldopamine, has been developed to meet the need for an orally effective positive inotropic agent for the treatment of chronic heart failure. Ibopamine is orally effective at daily doses of 100 -350 mg with a duration of action of 4 -5 h [70].…”